Edition:
United Kingdom

Gerresheimer AG (GXIG.DE)

GXIG.DE on Xetra

62.20EUR
4:35pm GMT
Change (% chg)

€-1.35 (-2.12%)
Prev Close
€63.55
Open
€63.45
Day's High
€64.05
Day's Low
€61.65
Volume
133,772
Avg. Vol
135,150
52-wk High
€80.25
52-wk Low
€51.10

Latest Key Developments (Source: Significant Developments)

Gerresheimer Says Q4 Adjusted EBITDA -3.9 Percent At 101 Million EUR
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Gerresheimer AG ::SAYS REVENUES AT CONSTANT EXCHANGE RATES UP 4.3% IN THE FINANCIAL YEAR 2018 TO EUR 1,406.7M.SAYS ADJUSTED EBITDA AT CONSTANT EXCHANGE RATES AT EUR 307.5M, EXCLUDING THE ADVANCED TECHNOLOGIES DIVISION AND OTHER ONE-OFF EFFECTS, AND DESPITE SUBSTANTIALLY NEGATIVE ENERGY COSTS AND RESIN PRICES.SAYS SENSILE MEDICAL ACQUIRED IN JULY 2018 AND SUCCESSFULLY INTEGRATED; NEW ADVANCED TECHNOLOGIES DIVISION ESTABLISHED.SAYS FURTHER INCREASE IN PROPOSED DIVIDEND TO EUR 1.15 PER SHARE (PRIOR YEAR: EUR 1.10).SAYS MEDIUM-TERM INDICATION: EXPECTING 4% TO 7% AVERAGE REVENUE GROWTH AT CONSTANT EXCHANGE RATES.SAYS THANKS TO Q4, INCREASED REVENUES AT CONSTANT EXCHANGE RATES BY 4.3% FROM EUR 1,348.3M TO EUR 1,406.7M IN THE FINANCIAL YEAR 2018.SAYS REVENUES ARE EXPECTED TO BE IN THE RANGE OF APPROXIMATELY EUR 1.4BN TO EUR 1.45BN IN THE FINANCIAL YEAR 2019.SAYS GERRESHEIMER PROJECTS ADJUSTED EBITDA OF APPROXIMATELY EUR 295M IN THE FINANCIAL YEAR 2019 (PLUS OR MINUS EUR 5M).SAYS THERE IS OTHER OPERATING INCOME OF ROUGHLY EUR 90M IN THE FIRST QUARTER OF THE FINANCIAL YEAR 2019 DUE TO THE DERECOGNITION OF CONTINGENT CONSIDERATION FROM THE SENSILE MEDICAL ACQUISITION.SAYS CAPITAL EXPENDITURE AS A PERCENTAGE OF REVENUES WILL BE APPROXIMATELY 12% IN 2019.SAYS Q4 REVENUES 391.1 MILLION EUR, UP 1.4 PERCENT.SAYS Q4 ADJUSTED EBITDA 101 MILLION EURO, DOWN 3.9 PERCENT.  Full Article

Gerresheimer - Bernd Metzner To Become Chief Financial Officer
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Gerresheimer AG ::DR. BERND METZNER TO BECOME CHIEF FINANCIAL OFFICER OF GERRESHEIMER AG.METZNER TO TAKE UP OFFICE AT THE LATEST ON JULY 1, 2019.  Full Article

Gerresheimer CFO Says To Finance Takeover With Cash And Credit Lines
Thursday, 12 Jul 2018 

July 12 (Reuters) - Gerresheimer AG ::CFO SAYS SENSILE MEDICAL ACQUISITION SHOULD CLOSE ON 17.7.CFO SAYS TO FINANCE TAKEOVER WITH CASH AND GRANTED CREDIT LINES.  Full Article

Gerresheimer buys Sensile Medical; organic revenue outlook 2018 narrowed to upper end of range
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Gerresheimer AG ::GERRESHEIMER ACQUIRES SENSILE MEDICAL / IRRESPECTIVE OF THAT, INCREASED GROWTH AND IMPROVED PROFITABILITY EXPECTED MID-TERM DUE TO TWO NEW MAJOR ORDERS WITH TEMPORARILY HIGHER CAPEX / ORGANIC REVENUE GUIDANCE 2018 NARROWED TO UPPER END OF RANG.DEPENDING ON ATTAINMENT OF CONTRACTUALLY SPECIFIED MILESTONES, PURCHASE PRICE WILL BE A MAXIMUM OF EUR 350 MLN.INITIAL PAYMENT IS EUR 175 MLN.IN YEARS 2021 AND 2022, EXPECTS, EXCLUDING SENSILE MEDICAL,THAT REVENUES,ADJUSTED EBITDA MARGIN WILL INCREASE BY TWO PERCENTAGE POINTS.ANTICIPATES DEAL WILL LEAD IN 2019 AND 2020 TO APPROXIMATELY ONE-PERCENTAGE-POINT REDUCTION IN ADJUSTED EBITDA MARGIN.SEES STRONG SECOND HALF; NARROWED FORECAST FOR REVENUES TO UPPER END OF GUIDANCE RANGE, AT EUR 1.38 BLN TO EUR 1.4 BLN.  Full Article

Gerresheimer sees significant boost from U.S. tax reform​
Tuesday, 23 Jan 2018 

Jan 23 (Reuters) - Gerresheimer Ag ::EXPECTS SIGNIFICANT POSITIVE EFFECTS FROM US TAX REFORM IN 2018​.SAYS EXPECTS ONE-TIME DEFERRED TAX BENEFIT OF ‍BETWEEN USD 50 MILLION AND USD 55 MILLION FOR 2018 FINANCIAL YEAR, RECORDED IN Q1 OF 2018.​.  Full Article

Gerresheimer says acquisitions remain part of strategy
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Gerresheimer AG management on conference call::CEO says wants to expand customer base in emerging markets‍​.CFO says acquisitions remain part of its strategy.  Full Article

German stocks - Factors to watch on Feb. 14

BERLIN, Feb 14 The following are some of the factors that may move German stocks on Thursday: